Patent · US Active

Method for the production of permanent human cell lines

US9315773B2 · kind B2 · utility

5Cited by

4References

21Claims

0Family size

Assignee

CEVEC Pharmaceuticals GmbH · DE

Inventors

Gudrun Schiedner · Cologne, DE
Christoph Volpers · Wiesbaden, DE

Key dates

Filing date	Dec 19, 2014
Grant date	Apr 19, 2016
Priority date	—
Expiry date	Dec 19, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2799/06
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to a method for the production of a permanent human cell line, wherein isolated primary human cells are transfected simultaneously with a sequence allowing the expression of at least one cell transforming factor and a sequence allowing the expression of at least one recombinant polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.